par Goldman, Serge 
;Bron, Dominique ;Tousseyn, Thomas;Vierasu, Irina;Dewispelaere, Laurent ;Heimann, Pierre ;Cogan, Elie ;Goldman, Michel
Référence Frontiers in Medicine, 8, 798095
Publication Publié, 2021-11
;Bron, Dominique ;Tousseyn, Thomas;Vierasu, Irina;Dewispelaere, Laurent ;Heimann, Pierre ;Cogan, Elie ;Goldman, Michel Référence Frontiers in Medicine, 8, 798095
Publication Publié, 2021-11
Article révisé par les pairs
| Résumé : | Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL. |
